Regulating Urine pH Levels to Alleviate Chronic Joint Pain
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01421160
Recruitment Status :
(PI left the institution prior to any data being collected)
First Posted : August 22, 2011
Last Update Posted : May 16, 2017
Texas Tech University Health Sciences Center, El Paso
Information provided by (Responsible Party):
Dennis Miller, Texas Tech University Health Sciences Center, El Paso
This study aims to determine the causal relationship between regulating urine pH levels between 7.0 and 7.5 and decreasing chronic joint pain. The investigators hypothesize that maintenance of an alkaline urinary pH will result in a decrease in personally reported levels of chronic joint pain using a citrate treatment regimen.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
21 Years to 80 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Presence of joint pain of perceived inflammatory and non-inflammatory origin for more than six months. More specifically:
Subjects with osteoarthritis (OA) of the knee will be preferred for inclusion in this study.
Subjects with other joint pain history will be included pursuant on approval from Dr. Miller or Dr. Pema.
Age 21 to 80 years old and otherwise in good health (excluding the joint pain).
Able to understand and comply with the assigned urine alkalinization instructions.
Has a working and reliable telephone number for continued contact as necessary during the study.
Ability to obtain X-rays of the affected joint. Imaging of the painful joint will be necessary at the beginning of the study for baseline considerations; if images from the last 6 months are available, no new imaging would be necessary.
Ability to obtain lab tests (Complete Blood Count and Comprehensive Metabolic Panel) or can obtain documentation of recent lab tests that have been taken within one month prior to enrollment.
Ability to obtain lab tests at 3 and 6 months during participation in the study.
Presence of joint pain with known joint osseous changes.
Pregnant or lactating women will not be enrolled in the study.
Positive medical history of:
Psychiatric diseases and conditions, including anxiety, depression, PTSD, distress
Dementia or other memory disturbances
Alcoholism or substance abuse
Renal failure and/or abnormal renal function (kidney disease or dysfunction). Specifically, Creatinine (Creat) values that are over 1.2mg/dL and Urea Nitrogen (BUN) values that are over 22mg/dL are considered abnormal.
No history of cardiovascular disease, intestinal angina or arrhythmias
No history of sodium restrictions
Pt. should not be taking medications which produce pain such as angiotensin converting enzyme (ACE) inhibitors and Statins (Lisinopril, Quinapril, Ramipril)
Does not have reliable telephone communication.
Does not have the ability to obtain an X-ray and does not have the ability to obtain documentation of a recent X-ray within the last six months.
Does not have the ability to obtain lab tests (Complete Blood Count and Comprehensive Metabolic Panel) and does not have the ability to obtain documentation of recent lab tests that have been taken within one month prior to enrollment.
Does not have the ability to obtain lab tests at 3 and 6 months during participation in the study.